Andreas Katopodis

City:

Basel

Country:

Switzerland

Published Applications:

Last publication date:

2024-11-07

Top Assignees for applications by Andreas Katopodis

The entities that hold a legal rights for patent applications filed by inventor Katopodis Andreas:

UNIVERSITAT ZURICH 3 Zurich, Switzerland
ImmunoFree, Inc. 1 Greenwich, CT United States
UNIVERSITÄT ZÜRICH 1 Zürich, Switzerland
NOVARTIS AG 1 Basel, Switzerland
Priothera Limited 1 Dublin, Ireland
UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION 1 Louisville, KY United States
Anaveon AG 1 Basel, Switzerland

Recent patent applications by Katopodis Andreas

Andreas Katopodis from Basel, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-11-07

US20240368266A1

Chemistry; metallurgy

IMMUNE-STIMULATING HUMANIZED MONOCLONAL ANTIBODIES AGAINST HUMAN INTERLEUKIN-2, AND FUSION PROTEINS THEREOF

#2 | 2024-05-16

US20240158491A1

Chemistry; metallurgy

IMMUNE-STIMULATING IL-2 FUSION PROTEINS

#3 | 2023-10-03

US17817886

Chemistry; metallurgy

Immune-stimulating IL-2 fusion proteins

#4 | 2021-11-11

US20210346317A1

Human necessities

TREATMENT OF HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS

#5 | 2021-08-12

US20210246200A1

Chemistry; metallurgy

Immune-stimulating humanized monoclonal antibodies against human interleukin-2, and fusion proteins thereof

#6 | 2021-05-13

US20210140975A1

Physics

METHODS AND COMPOSITIONS FOR DETERMINING THE POTENCY OF A THERAPEUTIC CELLULAR COMPOSITION

#7 | 2019-01-24

US20190022033A1

Human necessities

TREATMENT OF HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS

#8 | 2019-01-17

US20190016797A1

Chemistry; metallurgy

Immune-stimulating humanized monoclonal antibodies against human interleukin-2, and fusion proteins thereof

#9 | 2018-09-06

US20180252729A1

Physics

METHODS AND COMPOSITIONS FOR DETERMINING THE POTENCY OF A THERAPEUTIC CELLULAR COMPOSITION

InventorID:

2287671 ⎘